VKTX CIK: 1607678

Viking Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−47.6
FY22:
−48.4
FY23:
−73.4
FY24:
−87.8
FY25:
−279
Change from FY21 to FY25
millions USD
FY21:
38.0
FY22:
54.8
FY23:
−179
FY24:
−553
FY25:
341
Change from FY21 to FY25
millions USD
FY21:
6.88
FY22:
4.16
FY23:
271
FY24:
612
FY25:
76.4
millions USD
FY21:
−2.75
FY22:
10.5
FY23:
–
FY24:
–
FY25:
–

All amounts in millions USD Data source:SEC EDGAR